Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of October 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity:
- Shares Purchased: 1,500,000 ordinary shares.
- Purchase Date: September 30, 2025.
- Price Range: Highest price paid was 333.30 pence; lowest was 328.40 pence.
- Volume Weighted Average Price: 331.3782 pence per share.
- Treasury Shares: Following settlement, 44,400,783 shares are held as treasury shares.
- Voting Rights: 8,907,952,865 ordinary shares with voting rights remain outstanding.
Material Changes
The primary material change is the reduction of outstanding shares with voting rights due to the second tranche of the share buyback programme announced on July 31, 2025. The company intends to hold the purchased shares as treasury shares.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation of an offer for securities.
Investor Verification Checklist
- Verify the total number of treasury shares held (44,400,783) against the company's latest capital structure.
- Confirm the remaining capacity under the share buyback programme announced on July 31, 2025.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular execution details.
- Check the updated number of shares with voting rights (8,907,952,865) for compliance with disclosure thresholds under FCA rules.